Holen Sie sich die Stockscreener-App
101.74
1.07%
1.08
Schlusskurs vom Vortag:
$100.66
Offen:
$100.87
24-Stunden-Volumen:
467.71K
Relative Volume:
0.74
Marktkapitalisierung:
$6.79B
Einnahmen:
$136.86M
Nettoeinkommen (Verlust:
$-168.69M
KGV:
-36.21
EPS:
-2.81
Netto-Cashflow:
$-113.49M
1W Leistung:
+2.34%
1M Leistung:
-5.05%
6M Leistung:
+63.02%
1J Leistung:
+72.35%
1-Tages-Spanne:
$98.52
$103.78
1-Wochen-Bereich:
$98.52
$108.99
52-Wochen-Spanne:
$45.91
$116.00
Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
Firmenname
Rhythm Pharmaceuticals Inc
Sektor
Branche
Telefon
857-264-4280
Adresse
222 BERKELEY STREET, BOSTON, MA
Vergleichen Sie RYTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RYTM
Rhythm Pharmaceuticals Inc
|
101.74 | 6.72B | 136.86M | -168.69M | -113.49M | -2.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-07-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-03-05 | Fortgesetzt | Stifel | Buy |
| 2025-01-02 | Eingeleitet | Jefferies | Buy |
| 2024-12-20 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Guggenheim | Buy |
| 2024-09-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-17 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-01 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-01-18 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-08-08 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-06-17 | Bestätigt | Needham | Buy |
| 2022-03-02 | Fortgesetzt | Stifel | Buy |
| 2022-02-17 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-14 | Fortgesetzt | Goldman | Neutral |
| 2021-08-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-08-04 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-08 | Eingeleitet | Goldman | Sell |
| 2019-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-07-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-03-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-09-07 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-06-25 | Bestätigt | Needham | Buy |
| 2018-06-15 | Bestätigt | Needham | Buy |
| 2017-10-30 | Eingeleitet | BofA/Merrill | Buy |
| 2017-10-30 | Eingeleitet | Needham | Buy |
Alle ansehen
Rhythm Pharmaceuticals Inc Aktie (RYTM) Neueste Nachrichten
Will Rhythm Pharmaceuticals Inc. (1RV) stock enhance shareholder valueOil Prices & Fast Exit/Entry Strategy Plans - newser.com
Can Rhythm Pharmaceuticals Inc. stock rebound after recent weakness2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Is Rhythm Pharmaceuticals Inc. (1RV) stock expanding market penetration2025 Top Decliners & Free Low Drawdown Momentum Trade Ideas - newser.com
Why analysts recommend Rhythm Pharmaceuticals Inc. (1RV) stock2025 Performance Recap & Real-Time Buy Signal Notifications - newser.com
Rhythm Pharmaceuticals Ranked 31st on Deloitte Fast 500 List - citybiz
Will Rhythm Pharmaceuticals Inc. (1RV) stock profit from automation waveWeekly Gains Summary & Daily Stock Trend Watchlist - newser.com
Why Rhythm Pharmaceuticals Inc. (1RV) stock is favored by hedge fundsSwing Trade & Weekly Top Performers Watchlists - newser.com
Can Rhythm Pharmaceuticals Inc. stock weather global recessionEarnings Growth Report & High Accuracy Swing Trade Signals - newser.com
Is it time to cut losses on Rhythm Pharmaceuticals Inc.Layoff News & Long-Term Growth Stock Strategies - newser.com
Why retail investors favor Rhythm Pharmaceuticals Inc. stockWeekly Trade Recap & Precise Trade Entry Recommendations - newser.com
Can machine learning forecast Rhythm Pharmaceuticals Inc. recoveryWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
Can Rhythm Pharmaceuticals Inc. (1RV) stock hold up in economic slowdownWeekly Gains Report & Free Fast Gain Swing Trade Alerts - newser.com
Is Rhythm Pharmaceuticals Inc. (1RV) stock supported by free cash flow2025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Finanzdaten der Rhythm Pharmaceuticals Inc-Aktie (RYTM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):